Literature DB >> 1819274

Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin.

J Courty1, M C Dauchel, D Caruelle, M Perderiset, D Barritault.   

Abstract

A growth factor was isolated from a neutral pH extract of adult bovine brain. Purification of this polypeptide was achieved by a three step procedure including cationic exchange, heparin-Sepharose affinity and Mono S chromatography. This heparin binding protein had a molecular weight of 18,000 as assessed by silver-stained SDS-PAGE and was not immunologically and structurally related to acidic or basic FGF. Freshly purified protein had a maximal mitogenic effect on bovine brain capillary cells at a concentration of 100 pM. Microsequencing revealed an unique amino-terminal sequence homologous to heparin-binding growth-associated molecule (HB-GAM), a neuronal maturation protein, to pleiotrophin (PTN), a fibroblast cell growth factor and to one form of the putative protein product of the MK gene, a retinoic acid induced-gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819274     DOI: 10.1016/s0006-291x(05)81267-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C.

Authors:  Harold Pariser; Gonzalo Herradon; Laura Ezquerra; Pablo Perez-Pinera; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

2.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Authors:  Weiwen Wang; Michelle E LeBlanc; Xiuping Chen; Ping Chen; Yanli Ji; Megan Brewer; Hong Tian; Samantha R Spring; Keith A Webster; Wei Li
Journal:  Angiogenesis       Date:  2017-04-26       Impact factor: 9.596

4.  Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation.

Authors:  Brigitte Blondet; Gilles Carpentier; Arnaud Ferry; José Courty
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

5.  Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.

Authors:  Marius Grzelinski; Florian Steinberg; Tobias Martens; Frank Czubayko; Katrin Lamszus; Achim Aigner
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis.

Authors:  Zoi Diamantopoulou; Paraskevi Kitsou; Suzanne Menashi; Jose Courty; Panagiotis Katsoris
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

8.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

9.  A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ.

Authors:  Zoi Diamantopoulou; Oya Bermek; Apostolos Polykratis; Yamina Hamma-Kourbali; Jean Delbé; José Courty; Panagiotis Katsoris
Journal:  Mol Cancer       Date:  2010-08-25       Impact factor: 27.401

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.